Address
4 Science Park
New Haven, CT 06511
United States of America (the)
Phone
203 787 7888
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
54
First IPO Date
June 30, 2017
| Name | Title | Pay | Year Born |
| Ilan Danieli | Founder, President, Chief Executive Officer & Director | 427,124 | 1972 |
| Ahmed Zaki Sabet | Chief Operating Officer | 274,532 | 1985 |
| Ayman Mohamed | Chief Technology Officer | 277,896 | 1984 |
| Matthew Gage | Chief Financial Officer | 0 | 1967 |
| Miri Chiko-Radomski | Chief Legal Counsel & People Officer | 0 | N/A |
Precipio, Inc., based in New Haven, Connecticut, functions as a healthcare solutions provider within the United States. The company delivers a range of diagnostic products, reagents, and services, specifically offering diagnostic testing for blood cancers. Its advanced offerings include IV-Cell, a unique cell culture media capable of simultaneously growing four types of hematopoietic cell lineages, and HemeScreen, a comprehensive collection of genetic diagnostic panels. Precipio also develops COVID-19 antibody tests. A notable proprietary innovation is ICE-COLD PCR, a patented technology designed to boost the sensitivity of molecular tests, with kits for this technology also sold to biopharmaceutical customers. Additionally, Precipio, Inc. collaborates with academic institutions dedicated to cancer research, diagnosis, and therapy.